Quick recap
Growth strategy focused on China's infant milk formula market
Full-year results show double-digit revenue and earnings growth
China sales up 38%, record market share in China label IMFMarketing investment up 13% to $260m boosts
China brand healthTotal IMF sales rise 8% despite market decline of 14%
China IMF market decline due to fewer newborns and increased competition
Revenue grows 10.1% to $1,592.9 million with varied regional sales
EBITDA up 11.8% to $219.3 million
NPAT up 26.2% to $144.8 million
Earnings per share rise 28.7% to 21.2 cents
Company expects growth in FY24 despite market challenges.
- Forums
- ASX - By Stock
- Ann: FY23 Annual Report
Quick recapGrowth strategy focused on China's infant milk...
-
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.72 |
Change
-0.020(0.30%) |
Mkt cap ! $4.858B |
Open | High | Low | Value | Volume |
$6.81 | $6.89 | $6.68 | $14.52M | 2.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13046 | $6.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.73 | 17123 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9925 | 6.680 |
2 | 6687 | 6.670 |
3 | 8037 | 6.660 |
2 | 14730 | 6.650 |
1 | 3131 | 6.640 |
Price($) | Vol. | No. |
---|---|---|
6.730 | 17123 | 4 |
6.740 | 12987 | 2 |
6.750 | 15146 | 3 |
6.760 | 7249 | 1 |
6.790 | 3755 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |